Korean CDMO ST Pharm accelerates manufacturing of RNA-based vaccines therapeutics with Quantoom Biosciences

ST Pharm, a leading technology-driven RNA CDMO based in South Korea, and Belgium-based Quantoom Biosciences, a specialis...

August 20, 2024 | Tuesday | News
Andelyn Biosciences Expands AAV Curator™ Platform with Broad Institute's MyoAAV Plasmids

Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Or...

August 7, 2024 | Wednesday | News
Novo Nordisk and Bio Farma announce partnership for insulin production in Indonesia

Novo Nordisk Indonesia and Bio Farma have announced the signing of a Memorandum of Understanding (MoU) to collaborate in...

July 29, 2024 | Monday | News
Merck expands production capabilities for cell culture media with €6.6 M investment at Nantong site

Merck has announced the start of commercial production of its first GMP (Good Manufacturing Practices) compliant manufac...

July 16, 2024 | Tuesday | News
Japan's Eisai terminates ADC manufacturing pact with BMS

Japan-based pharmaceutical firm Eisai Co. has agreed to end its global strategic collaboration with Bristol Myers Squibb...

July 3, 2024 | Wednesday | News
Taiwan's Bora Pharma buys US-based Emergent BioSolutions' manufacturing site for $30 M

US-based Emergent BioSolutions Inc. has entered into a definitive agreement to sell its drug product facility in Baltimo...

June 24, 2024 | Monday | News
Japan's Asahi Kasei to establish facility in US and launch plasmid DNA business

Asahi Kasei Medical's US subsidiary Bionova Scientific, a full-service biologics CDMO, has decided to launch a new busin...

June 4, 2024 | Tuesday | News
CPHI North America expanding Bioproduction focus for 2025

CPHI North America reports soaring attendance and palpable excitement on the show floor, as investment returns and biolo...

May 9, 2024 | Thursday | News
WuXi AppTec breaks ground on new R&D and manufacturing site in Singapore

WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies ...

May 23, 2024 | Thursday | News
Victorian govt supports IDT to build Australia’s first commercial antibody drug conjugate manufacturing facility

IDT Australia has been awarded a Victoria State Government grant to part fund the establishment of Australia&rsq...

May 7, 2024 | Tuesday | News
Unleashing data’s potential in the pharmaceutical landscape

The life sciences industry is at a critical juncture in its digital transformation. Technological advancements including...

May 3, 2024 | Friday | Analysis
Ascend Advanced Therapies Acquires CMC Team and Facility in Florida from Beacon Therapeutics

 Ascend Advanced Therapies (Ascend), a total solutions gene therapy development partner, has acquired the CMC ...

April 9, 2024 | Tuesday | News
Celltrion picks Wood to expand Songdo biopharma manufacturing hub in South Korea

Wood, a global leader in consulting and engineering, has been selected by leading biopharmaceutical firm Celltrion to ...

April 8, 2024 | Monday | News
Novo Nordisk invests ¥4 B in China for sterile preparation expansion project

Danish pharma firm Novo Nordisk has announced that it would invest approximately 4 billion yuan (¥) in Tianjin for a...

March 22, 2024 | Friday | News
WuXi Biologics to establish new CRDMO facility in Singapore

China's WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organisation (CRDMO), has brok...

March 19, 2024 | Tuesday | News
Japan's Kyowa Kirin invests $200 M to build first North American pharma manufacturing operation

Kyowa Kirin has selected Lee County to build its first North American pharmaceutical manufacturing operation, creating...

March 11, 2024 | Monday | News
SK bioscience expands manufacturing facility in Korea for pneumococcal vaccine production

SK bioscience, South Korea-based vaccine and biotech company, has broken ground on a major expansion of its vaccine manu...

March 7, 2024 | Thursday | News
Australia's Telix Pharma buys radioisotope production technology firm ARTMS for $42.5 M

Australia-based Telix Pharmaceuticals has entered into an agreement to acquire radioisotope production technology firm A...

March 6, 2024 | Wednesday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls